CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Polarean Imaging PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Polarean Imaging PLC
2500 Meridian Pkwy #175
Phone: (919) 206-7900p:919 206-7900 DURHAM, NC  27713  United States Ticker: POLXPOLX
Business Summary
Polarean Imaging plc is a medical-imaging technology company, revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of magnetic resonance imaging (MRI) to the respiratory healthcare community. The Company and its subsidiary company, Polarean, Inc., operate as investigational drug-device combination companies operating in the high-resolution medical imaging research space. The Company has developed the hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW (xenon Xe 129 hyperpolarized). It develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue membrane, and into the pulmonary bloodstream. Its technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
3826 Laboratory analytical instruments
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board KennethWest 1/1/2023 12/23/2020
Chief Executive Officer, Executive Director Christopher R.Von Jako 53 6/20/2023 6/20/2023
Chief Financial Officer, Executive Director Charles F.Osborne 58 2/22/2021 2/22/2021
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Polarean Inc.
POLX

General Information
Number of Employees: 29 (As of 12/31/2023)
Outstanding Shares: 1,207,032,781 (As of 6/30/2024)
Stock Exchange: LON
Fax Number: (919) 206-7901


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025